Global vaccine action plan lessons learned I: Recommendations for the next decade

MacDonald, Noni E.; Mohsni, Ezzeddine; Al-Mazrou, Yagob Y.; Andrus, Jon Kim; Arora, Narendra K.; Elden, S; Madrid, Marie-Yvette; Martin, Rebecca; Mustafa, Amani Mahmoud; Rees, Helen; Salisbury, David; Zhao, Qinjian; Jones, Ian M.; Steffen, Christoph; Hombach, Joachim; O’Brien, Katherine L.; Cravioto, Alejandro

doi:10.1016/j.vaccine.2020.05.003

Cited by 68 publications

(59 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This goal can be realized by giving more resources to vaccination programs, implementing advanced vaccination programs, and developing activities to reduce vaccine hesitancy and increase vaccine confidence. The recommendations to improve the Global Vaccine Action Plan include developing a more country-focused approach, providing technical assistance according to specific needs, and considering immunization programs as one part of integrated disease control programs [ 38 , 39 ]. The Global Routine Immunization Strategies and Practices document of WHO [ 11 ] proposes the following transformative investments to reassert immunization as the foundation of sustained decreases in morbidity and mortality from vaccine-preventable diseases: (1) invest in a national team to expertly manage national vaccination programs, (2) invest in strategies to identify and immunize undervaccinated and unvaccinated persons, (3) invest in vaccinators and district managers, (4) invest in modernizing vaccine supply chains and management, and (5) invest in information systems that identify and tracks each person’s immunization status.…”

Section: Discussionmentioning

confidence: 99%

Vaccination Coverage for Routine Vaccines and Herd Immunity Levels against Measles and Pertussis in the World in 2019

Plans-Rubió

2021

Vaccines

View full text Add to dashboard Cite

In 2012, the World Health Organization (WHO) established the Global Vaccine Action Plan with the objective to promote essential vaccinations in all countries and achieve at least 90% vaccination coverage for all routine vaccines by 2020. The study assessed the mean percentages of vaccination coverage in 2019 for 13 routine vaccines, vaccination coverage variation from 2015 to 2019, and herd immunity levels against measles and pertussis in 2019 in countries and regions of WHO. In 2019, the mean percentages of vaccination coverage were lower than 90% for 10 (78.9%) routine vaccines. The mean percentages of vaccination coverage also decreased from 2015 to 2019 for six (46.2%) routine vaccines. The prevalence of individuals with vaccine-induced measles immunity in the target measles vaccination population was 88.1%, and the prevalence of individuals with vaccine-induced pertussis immunity in the target pertussis vaccination population was 81.1%. Herd immunity against measles viruses with Ro = 18 was established in 63 (32.5%) countries but not established in any region. Herd immunity against pertussis agents was not established in any country and in any region of WHO. National immunization programs must be improved to achieve ≥90% vaccination coverage in all countries and regions. Likewise, it is necessary to achieve ≥95% vaccination coverage with two doses of measles vaccines and three doses of pertussis vaccines in all countries and regions.

show abstract

Section: Discussionmentioning

confidence: 99%

Vaccination Coverage for Routine Vaccines and Herd Immunity Levels against Measles and Pertussis in the World in 2019

Plans-Rubió

2021

Vaccines

View full text Add to dashboard Cite

show abstract

“…Among coping strategies for emerging infectious diseases, preventive vaccination is a crucial strategy [2] and the only one with wide and thorough effects on the public health. For example, since 2000, vaccination has reduced the reported incidence of measles by 83%, thereby preventing over 20 million deaths [3] . Vaccines work by training and utilizing the body’s immune system to recognize and fight the pathogens.…”

Section: Introductionmentioning

confidence: 99%

Prophylactic vaccine delivery systems against epidemic infectious diseases

Pan¹,

Yue

Zhu³

et al. 2021

Advanced Drug Delivery Reviews

View full text Add to dashboard Cite

Prophylactic vaccines have evolved from traditional whole-cell vaccines to safer subunit vaccines. However, subunit vaccines still face problems, such as poor immunogenicity and low efficiency, while traditional adjuvants are usually unable to meet specific response needs. Advanced delivery vectors are important to overcome these barriers; they have favorable safety and effectiveness, tunable properties, precise location, and immunomodulatory capabilities. Nevertheless, there has been no systematic summary of the delivery systems to cover a wide range of infectious pathogens. We herein summarized and compared the delivery systems for major or epidemic infectious diseases caused by bacteria, viruses, fungi, and parasites. We also included the newly licensed vaccines (e.g., COVID-19 vaccines) and those close to licensure. Furthermore, we highlighted advanced delivery systems with high efficiency, cross-protection, or long-term protection against epidemic pathogens, and we put forward prospects and thoughts on the development of future prophylactic vaccines.

show abstract

“…The global vaccine action plan (GVAP) central vision is a world free from vaccine-preventable diseases [1]. Since 2010, immunization has contributed significantly to reducing a quarter of the number of child deaths due to vaccine-preventable disease worldwide, from 52 to 39 deaths per 1,000 live births [2].…”

Section: Introductionmentioning

confidence: 99%

Interventions to improve vaccination coverage of children in hard-to-reach population: A systematic review

Pitaloka

Handayani

2021

IJPHS

View full text Add to dashboard Cite

In the last decade, vaccination has reduced a quarter of child deaths worldwide. Vaccination coverage increased, but the coverage remains low in the hard-to-reach population. We searched articles from Pubmed MEDLINE, SCOPUS, Web of Science, and Science Direct to systematically review interventions to improve children's vaccination coverage in hard-to-reach populations. The expected outcome was vaccination coverage, which mentioned Odds Ratio, mean difference, or difference-in-difference with a 95% CI or p-value. Out of 102 articles identified, five articles from four different countries met the inclusion criteria. Four of the five studies reported a positive impact in increasing vaccination coverage. Interventions that showed good effectiveness in increasing the coverage of childhood immunizations were the application of mHealth given to vaccinators, multiple interventions involving the community, modification of immunization schedules during outreach activities, and immunization screening cards. Despite the inconsistent finding, mHealth with SMS reminders was the most effective intervention to increase vaccination coverage and relatively low-cost. More research was needed in developing a strategic intervention to increase vaccination coverage of children in hard-to-reach populations.

show abstract

Global vaccine action plan lessons learned I: Recommendations for the next decade

Cited by 68 publications

References 17 publications

Vaccination Coverage for Routine Vaccines and Herd Immunity Levels against Measles and Pertussis in the World in 2019

Vaccination Coverage for Routine Vaccines and Herd Immunity Levels against Measles and Pertussis in the World in 2019

Prophylactic vaccine delivery systems against epidemic infectious diseases

Interventions to improve vaccination coverage of children in hard-to-reach population: A systematic review

Contact Info

Product

Resources

About